I think the lack of any revenue announcement is the bad thing. Some may have unrealistic expectations but when an officer of the company says "we are there" in reference to comercializing Lympro and the official site has a chart that shows it is commercialized people become doubtful. These trials will cost them money, along with their recent acquisitions. Money going out so far nothing to show if and when anything will come in.